Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial to Evaluate Options for Second-line Therapy in Patients Failing a First-line 2NRTI + NNRTI Regimen in Africa

NCT00988039 is registered in ClinicalTrials.gov with Justine Boles as lead sponsor.

NCT NCT00988039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial to Evaluate Options for Second-line Therapy in Patients Failing a First-line 2NRTI + NNRTI Regimen in Africa
Lead sponsor
Justine Boles
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
January 31, 2014
Enrollment
1,277 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, human immunodeficiency virus